相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples
Douglas B. Kell
ARCHIVES OF TOXICOLOGY (2010)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
Ines Esteves Baldeiras et al.
JOURNAL OF NEUROLOGY (2009)
A systems approach to prion disease
Daehee Hwang et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease
Catherine Pennington et al.
NEUROSCIENCE LETTERS (2009)
Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders
Ajay Singh et al.
PLOS PATHOGENS (2009)
Rapidly progressive dementia
Michael D. Geschwind et al.
ANNALS OF NEUROLOGY (2008)
Intracellular iron transport and storage: From molecular mechanisms to health implications
Elizabeth L. Mackenzie et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Pathophysiology of restless legs syndrome: Evidence for iron involvement
James R. Connor
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
Markus Otto et al.
METHODS (2008)
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin et al.
PROTEOMICS (2008)
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
Anders Skinningsrud et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice
Boe-Hyun Kim et al.
NEUROSCIENCE LETTERS (2007)
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
Pascual Sanchez-Juan et al.
JOURNAL OF NEUROLOGY (2007)
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance
U. Heinemann et al.
BRAIN (2007)
Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease
Katsuya Satoh et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Pathogenesis of prion diseases: current status and future outlook
Adriano Aguzzi et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
S. J. Collins et al.
BRAIN (2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD
Natividad Cuadrado-Corrales et al.
BMC NEUROLOGY (2006)
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping
Chiara Piubelli et al.
PROTEOMICS (2006)
Ferritin subunits in CSF are decreased in restless legs syndrome
SL Clardy et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Separation of β2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids
T Görögh et al.
CLINICAL CHEMISTRY (2005)
Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease
B Van Everbroeck et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2005)
CSF iron, ferritin and transferrin levels in restless legs syndrome
S Mizuno et al.
JOURNAL OF SLEEP RESEARCH (2005)
Consensus paper of the WFSBP Task Force on biological markers of dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
J Wiltfang et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2005)
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY (2004)
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease
RJ Castellani et al.
NEUROLOGY (2004)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
MD Geschwind et al.
ARCHIVES OF NEUROLOGY (2003)
Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury
G Franz et al.
NEUROLOGY (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Transmission of prions
C Weissmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease
AJE Green et al.
NEUROLOGY (2001)
Tau protein in cerebrospinal fluid (CSF):: a blood-CSF barrier related evaluation in patients with various neurological diseases
SD Süssmuth et al.
NEUROSCIENCE LETTERS (2001)
Transferrin and transferrin receptor function in brain barrier systems
T Moos et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
分享论文
